U.S. Life Sciences Stock News

Diversified Energy (DEC) has completed a US$200 million tap-on offering of 9.75% senior secured bonds in the Nordic market, a move that directly affects its capital structure and funding flexibility. See our latest analysis for Diversified Energy. The bond tap comes after a period of weaker share price momentum, with a 90 day share price return showing a decline of 10.39% and a 1 year total shareholder return showing a decline of 16.86%. This points to pressure that has built up over several...

Pfizer (NYSE:PFE) received FDA Priority Review for a potential HYMPAVZI label expansion for pediatric and inhibitor-positive hemophilia patients. The company launched TrumpRx, a new affordability initiative linked to a Most Favored Nation agreement in the US. Pfizer joined BaseLaunch to support early stage biotech ventures in Europe. For you as an investor, these updates sit at the core of what Pfizer does as a large, diversified pharma group, balancing mature products with newer therapies...

Ryan Specialty Holdings (RYAN) is heading into an earnings report with attention sharpened by several moving pieces, including contentious Florida insurance legislation, new insurance focused AI tools, and a fresh expansion push in Canada. See our latest analysis for Ryan Specialty Holdings. Despite the headline risk around Florida legislation and questions about how new AI tools could affect brokerage models, Ryan Specialty’s 1 day share price return of 2.51% to US$44.88 comes after a 30 day...

United Therapeutics reported positive TETON-2 study results for inhaled treprostinil in idiopathic pulmonary fibrosis (IPF). The data indicate a potential role for inhaled treprostinil in helping stabilize lung function for IPF patients. The FDA qualified the PROLIFIC Risk Score, a tool designed to identify IPF patients at higher risk of rapid progression and support more targeted clinical trials. United Therapeutics (NasdaqGS:UTHR) is drawing attention as it pairs clinical momentum with a...

Why the new lawsuit matters for uniQure stock A fresh securities fraud class action against uniQure (NasdaqGS:QURE) is putting a spotlight on how the company previously described AMT-130’s pivotal Huntington’s disease data and its interactions with the FDA. The complaint challenges earlier messaging around biomarker results, comparisons with the ENROLL HD dataset, and the timeline for a potential Biologics License Application, which together influence how investors assess uniQure’s regulatory...

Choice Hotels International has recently rolled out a redesigned Everhome Suites prototype that targets roughly 13% lower development costs per room, greater operational efficiency, and a more modern, apartment-style extended stay experience, while also continuing to expand the brand to 27 open properties with additional locations in Texas, Kentucky, and New Jersey. This combination of a leaner, more scalable prototype and a growing national footprint could meaningfully influence how...

Recent trading in Customers Bancorp (CUBI) has drawn attention after a one-month return of about a 7% decline, alongside an 8.6% gain over the past 3 months, prompting fresh questions about valuation and earnings power. See our latest analysis for Customers Bancorp. At a share price of $73.14, Customers Bancorp has seen short term momentum ease, with a 7 day share price return of a 6.6% decline, while the 1 year total shareholder return of 25.9% and 5 year total shareholder return of 172.8%...

For readers wondering whether Mattel, at around US$21.06, is offering fair value right now or if the market is mispricing the toy maker, this article walks through what the numbers actually say about the stock. The share price is US$21.06 after a 0.6% decline over the last 7 days, a 2.0% decline over 30 days, a 5.1% gain year to date and a 3.6% decline over the past year. These moves give mixed signals when you compare them with its 13.5% and 12.9% annualized returns over 3 and 5...

Investors are watching Bright Horizons Family Solutions (BFAM) ahead of Thursday afternoon’s earnings, after the child care provider exceeded analyst expectations on revenue and adjusted earnings last quarter. The company enters this release with forecasts for slower, but still solid, year-on-year growth. See our latest analysis for Bright Horizons Family Solutions. At a share price of $85.04, Bright Horizons has seen a 17.0% 1 month share price return decline and a 14.4% year to date share...

In late January 2026, Viavi Solutions Inc. reported second-quarter 2025 sales of US$369.3 million, up from US$270.8 million a year earlier, alongside a net loss of US$48.1 million, issued third-quarter revenue guidance of US$386 million to US$400 million, and filed a US$220.82 million shelf registration for 10,500,000 common shares tied to an ESOP-related offering. The combination of strong top-line growth despite losses, new revenue guidance, and an employee stock plan-related shelf...

Sonos (SONO) is back in focus after a quarter where sales held around last year’s level, yet net income and earnings per share were much higher, helped by cost controls and product mix changes. See our latest analysis for Sonos. The earnings beat and recent buyback activity have coincided with a sharp shift in sentiment, with a 19.3% 7 day share price return and a 31.9% 1 year total shareholder return contrasting with weaker 3 and 5 year total shareholder returns. This suggests momentum has...

SMX (Security Matters) recently amended its equity line of credit, lifting the total capital commitment to US$250 million and extending its financing runway into 2028 to support brand protection, authentication, and track-and-trace initiatives. This enlarged and longer-term funding pool gives SMX more flexibility to run multiple platform deployments simultaneously and pursue longer-horizon enterprise and government projects without compressing implementation timelines. Given the strong 7-day...

Broadcom (NasdaqGS:AVGO) has launched what it calls the industry's first Wi-Fi 8 access point and switch solution for AI-ready enterprise networks. The platform includes the BCM49438 accelerated processing unit and Trident X3+ Ethernet switch, designed to integrate AI acceleration, analytics, and end to end security. The new offering is aimed at large enterprises upgrading their network infrastructure for higher bandwidth, low latency, and security sensitive AI workloads. For you as an...

In early February 2026, Griffon Corporation reported first-quarter fiscal 2026 results showing sales of US$649.09 million and net income of US$64.39 million, alongside guidance of US$1.8 billion in full‑year revenue from continuing operations and a regular quarterly dividend of US$0.22 per share. On the same day, Griffon unveiled plans to become a pure‑play North American building products company through a new joint venture with ONCAP for its AMES North America business and a review of...

Recently, Raymond James Financial was swept up in a sector-wide pullback after fintech firm Altruist launched an AI-powered planning tool that automates tax strategy design and document creation for financial advisers. The reaction highlights how quickly investor sentiment can shift when new technology raises questions about the durability of human-centered wealth-management models and fee structures. We’ll now explore how these AI disruption concerns intersect with Raymond James Financial’s...

Earlier in February 2026, Tidal Real Estate Partners secured US$371.5 million in financing from Madison Realty Capital and KSL Capital Partners for The Nashville EDITION Hotel & Residences, with Walker & Dunlop arranging the capital for the 28-story luxury hotel and residential tower. Around the same time, Walker & Dunlop was also recognized as Fannie Mae’s largest DUS lender for 2025 and a top Freddie Mac Optigo lender, underscoring its scale and influence in multifamily and commercial real...

If you are wondering whether BioMarin Pharmaceutical's current share price lines up with its underlying worth, this article will walk you through what the numbers say and how to interpret them. The stock closed at US$59.66 most recently, with returns of 3.6% over the last 7 days, 1.2% over 30 days, 0.4% year to date, and a 6.1% decline over 1 year, alongside larger declines of 45.1% over 3 years and 29.8% over 5 years. Recent attention on BioMarin has focused on its rare disease drug...

Amazon.com (NasdaqGS:AMZN) is preparing a marketplace that lets publishers license content directly to AI developers. The company is also rapidly expanding Amazon Pharmacy same day prescription delivery to nearly 4,500 US cities and towns. Both moves point to a bigger push into AI infrastructure and healthcare delivery platforms beyond its core retail and cloud businesses. Amazon.com, trading at $206.96, sits at the center of two big shifts: AI content access and digital healthcare. The...

Salesforce (NYSE:CRM) is cutting nearly 1,000 jobs across multiple divisions, including some AI related teams. The company is reshuffling top leadership, replacing five senior executives and appointing six new leaders. These moves are tied to a sharper focus on AI, with the Agentforce platform at the center of Salesforce’s product and growth plans. Salesforce, best known for its customer relationship management software and cloud based tools, is now putting AI closer to the core of how it...

FDA declined to review Moderna's application for its mRNA based flu vaccine, citing issues with clinical trial design. Moderna disputes the FDA's basis for refusal, saying study designs had previously been agreed with regulators. The company plans to seek discussions with the FDA on next steps for its flu program and related respiratory vaccines. For investors watching Moderna (NasdaqGS:MRNA), this regulatory setback arrives after a period of mixed share performance. The stock is at...

IDEXX Laboratories (IDXX) is back in the spotlight after reporting fourth quarter and full year 2025 results, with higher sales, net income, and earnings per share, along with new 2026 revenue and EPS guidance. See our latest analysis for IDEXX Laboratories. The fresh earnings and 2026 outlook arrive after a mixed stretch for the share price, with a 1-day share price return of 1.05% and 7-day share price return of 2.21%. These gains are offset by a 30-day share price return decline of 9.37%...

In recent months, Republic Services reported softer quarterly results and stagnating unit volumes, despite five-year sales increasing at a compounded annual rate of 10.2% and maintaining an average operating margin of 18.9%. This combination of slowing volumes alongside historically solid revenue growth and profitability has raised fresh questions about competition, market saturation, and the potential need for price or investment shifts. We’ll now examine how concerns about stagnating sales...

Ellington Financial plans to redeem all outstanding shares of its Series A Preferred Stock at the end of February 2026. Following the redemption, the Series A Preferred Stock will be delisted from the NYSE. The move will retire this layer of preferred capital and end related dividend payments to Series A holders. For common shareholders of NYSE:EFC, this preferred stock redemption sits alongside a share price of $12.85 and a mixed recent return profile. The stock is up 2.0% over the past...

On 2 February 2026, Helios Technologies announced that Enovation Controls has expanded the OpenView display platform by adding CODESYS functionality, enabling customers to program both uControl controllers and OpenView HMI displays within a single industrial development environment and access CODESYS WebVisu for remote monitoring. This move deepens Helios’ open software approach, potentially making its platforms more attractive to OEMs and system integrators seeking interoperable, remotely...